The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AKERO THERAPEUTICS INC | COM | 00973Y108 | 13,620 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
ALLAKOS INC | COM | 01671P100 | 36,332 | 5,936,666 | SH | SOLE | 5,936,666 | 0 | 0 | ||
ALTIMMUNE INC | COM NEW | 02155H200 | 9,578 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
ALX ONCOLOGY HLDGS INC | COM | 00166B105 | 28,436 | 2,971,352 | SH | SOLE | 2,971,352 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 88,790 | 1,300,000 | SH | SOLE | 1,300,000 | 0 | 0 | ||
ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | 29,143 | 1,525,000 | SH | SOLE | 1,525,000 | 0 | 0 | ||
ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 25,815 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 8,448 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
BICYCLE THERAPEUTICS PLC | SPONSORED ADS | 088786108 | 46,520 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 1,607 | 399,801 | SH | SOLE | 399,801 | 0 | 0 | ||
CENTURY THERAPEUTICS INC | COM | 15673T100 | 4,550 | 460,075 | SH | SOLE | 460,075 | 0 | 0 | ||
COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | 5,472 | 510,000 | SH | SOLE | 510,000 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 82,365 | 1,700,000 | SH | SOLE | 1,700,000 | 0 | 0 | ||
DESIGN THERAPEUTICS INC | COM | 25056L103 | 46,774 | 2,797,501 | SH | SOLE | 2,797,501 | 0 | 0 | ||
DICE THERAPEUTICS INC | COM | 23345J104 | 22,009 | 1,085,251 | SH | SOLE | 1,085,251 | 0 | 0 | ||
DYNE THERAPEUTICS INC | COM | 26818M108 | 29,049 | 2,287,321 | SH | SOLE | 2,287,321 | 0 | 0 | ||
FULCRUM THERAPEUTICS INC | COM | 359616109 | 15,776 | 1,950,000 | SH | SOLE | 1,950,000 | 0 | 0 | ||
GERON CORP | COM | 374163103 | 4,680 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
IDEAYA BIOSCIENCES INC | COM | 45166A102 | 61,694 | 4,135,000 | SH | SOLE | 4,135,000 | 0 | 0 | ||
IMMUNOCORE HLDGS PLC | ADS | 45258D105 | 16,429 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
INSTIL BIO INC | COM | 45783C101 | 1,606 | 331,872 | SH | SOLE | 331,872 | 0 | 0 | ||
IVERIC BIO INC | COM | 46583P102 | 26,910 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
KARUNA THERAPEUTICS INC | COM | 48576A100 | 33,740 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 8,180 | 950,000 | SH | SOLE | 950,000 | 0 | 0 | ||
LIANBIO | SPONSORED ADS | 53000N108 | 616 | 307,908 | SH | SOLE | 307,908 | 0 | 0 | ||
NGM BIOPHARMACEUTICALS INC | COM | 62921N105 | 11,118 | 850,000 | SH | SOLE | 850,000 | 0 | 0 | ||
NUVATION BIO INC | *W EXP 07/07/202 | 67080N119 | 13 | 66,666 | SH | SOLE | 66,666 | 0 | 0 | ||
OLEMA PHARMACEUTICALS INC | COM | 68062P106 | 10,333 | 3,743,875 | SH | SOLE | 3,743,875 | 0 | 0 | ||
PYXIS ONCOLOGY INC | COMMON STOCK | 747324101 | 434 | 220,434 | SH | SOLE | 220,434 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 38,689 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
SPRUCE BIOSCIENCES INC | COM | 85209E109 | 1,370 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
TALARIS THERAPEUTICS INC | COM | 87410C104 | 521 | 197,913 | SH | SOLE | 197,913 | 0 | 0 | ||
TRICIDA INC | COM | 89610F101 | 9,956 | 950,000 | SH | SOLE | 950,000 | 0 | 0 | ||
TRICIDA INC | COM | 89610F101 | 2,517 | 240,200 | SH | Put | SOLE | 240,200 | 0 | 0 | |
TYRA BIOSCIENCES INC | COM | 90240B106 | 1,119 | 127,316 | SH | SOLE | 127,316 | 0 | 0 | ||
VENTYX BIOSCIENCES INC | COM | 92332V107 | 48,793 | 1,397,680 | SH | SOLE | 1,397,680 | 0 | 0 | ||
VIGIL NEUROSCIENCE INC | COM | 92673K108 | 1,871 | 205,595 | SH | SOLE | 205,595 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 20,510 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 18,050 | 500,000 | SH | SOLE | 500,000 | 0 | 0 |